382 related articles for article (PubMed ID: 29273890)
1. Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.
Attal J; Chaltiel L; Lubrano V; Sol JC; Lanaspeze C; Vieillevigne L; Latorzeff I; Cohen-Jonathan Moyal E
J Neurooncol; 2018 Jan; 136(2):413-419. PubMed ID: 29273890
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
[TBL] [Abstract][Full Text] [Related]
3. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.
Palmer JD; Siglin J; Yamoah K; Dan T; Champ CE; Bar-Ad V; Werner-Wasik M; Evans JJ; Kim L; Glass J; Farrell C; Andrews DW; Shi W
J Neurooncol; 2015 Sep; 124(2):215-21. PubMed ID: 26024653
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Review of Re-irradiating Patients' Recurrent High-grade Gliomas.
Klobukowski L; Falkov A; Chelimo C; Fogh SE
Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):563-570. PubMed ID: 29891395
[TBL] [Abstract][Full Text] [Related]
5. Patterns of re-irradiation for recurrent gliomas and validation of a prognostic score.
Post CCB; Kramer MCA; Smid EJ; van der Weide HL; Kleynen CE; Heesters MAAM; Verhoeff JJC
Radiother Oncol; 2019 Jan; 130():156-163. PubMed ID: 30446315
[TBL] [Abstract][Full Text] [Related]
6. Reirradiation of gliomas under stereotactic conditions: Prognostic factors for survival without relapse or side effects, a retrospective study at Tours regional university hospital (France).
Lévy S; Chapet S; Scher N; Debbi K; Ruffier A; Bernadou G; Pointreau Y; Calais G
Cancer Radiother; 2017 Dec; 21(8):759-765. PubMed ID: 29128197
[TBL] [Abstract][Full Text] [Related]
7. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
Gupta T; Maitre M; Maitre P; Goda JS; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Epari S; Sahay A; Patil V; Jalali R
Clin Transl Oncol; 2021 Jul; 23(7):1358-1367. PubMed ID: 33528810
[TBL] [Abstract][Full Text] [Related]
8. Radiologic Response and Disease Control of Recurrent Intracranial Meningiomas Treated With Reirradiation.
Lin AJ; Hui C; Dahiya S; Lu HC; Kim AH; Campian JL; Tsien C; Zipfel GJ; Rich KM; Chicoine M; Huang J
Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):194-203. PubMed ID: 29970312
[TBL] [Abstract][Full Text] [Related]
9. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.
Schernberg A; Dhermain F; Ammari S; Dumont SN; Domont J; Patrikidou A; Pallud J; Dezamis É; Deutsch É; Louvel G
Cancer Radiother; 2018 Feb; 22(1):9-16. PubMed ID: 29217134
[TBL] [Abstract][Full Text] [Related]
10. Fractionated stereotactic radiosurgery with volumetric modulated arc therapy (Rapid Arc) for reradiation in recurrent high grade gliomas.
Anand AK; Kumar P; Patir R; Vaishya S; Bansal AK; Chaudhoory AR; Punnakal AU; Malhotra H; Munjal RK
J Cancer Res Ther; 2014; 10(1):97-102. PubMed ID: 24762494
[TBL] [Abstract][Full Text] [Related]
11. Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.
Arvold ND; Shi DD; Aizer AA; Norden AD; Reardon DA; Lee EQ; Nayak L; Dunn IF; Golby AJ; Johnson MD; Claus EB; Chiocca EA; Ligon KL; Wen PY; Alexander BM
J Neurooncol; 2017 Dec; 135(3):581-591. PubMed ID: 28975467
[TBL] [Abstract][Full Text] [Related]
12. Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.
Shi W; Blomain ES; Siglin J; Palmer JD; Dan T; Wang Y; Werner-Wasik M; Glass J; Kim L; Bar Ad V; Bhamidipati D; Evans JJ; Judy K; Farrell CJ; Andrews DW
J Neurooncol; 2018 Mar; 137(1):171-177. PubMed ID: 29235052
[TBL] [Abstract][Full Text] [Related]
13. Quantitative dynamic susceptibility contrast perfusion-weighted imaging-guided customized gamma knife re-irradiation of recurrent high-grade gliomas.
Wang B; Zhao P; Zhang Y; Ge M; Lan C; Li C; Pang Q; Xu S; Liu Y
J Neurooncol; 2018 Aug; 139(1):185-193. PubMed ID: 29696532
[TBL] [Abstract][Full Text] [Related]
14. Validation of an established prognostic score after re-irradiation of recurrent glioma.
Kessel KA; Hesse J; Straube C; Zimmer C; Schmidt-Graf F; Schlegel J; Meyer B; Combs SE
Acta Oncol; 2017 Mar; 56(3):422-426. PubMed ID: 28075197
[TBL] [Abstract][Full Text] [Related]
15. Subventricular zones: new key targets for glioblastoma treatment.
Khalifa J; Tensaouti F; Lusque A; Plas B; Lotterie JA; Benouaich-Amiel A; Uro-Coste E; Lubrano V; Cohen-Jonathan Moyal E
Radiat Oncol; 2017 Apr; 12(1):67. PubMed ID: 28424082
[TBL] [Abstract][Full Text] [Related]
16. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
[TBL] [Abstract][Full Text] [Related]
17. Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis.
Pinzi V; Orsi C; Marchetti M; Milanesi IM; Bianchi LC; DiMeco F; Cuccarini V; Farinotti M; Ferroli P; Finocchiaro G; Franzini A; Fumagalli M; Silvani A; Fariselli L
Neurol Sci; 2015 Aug; 36(8):1431-40. PubMed ID: 25805705
[TBL] [Abstract][Full Text] [Related]
18. Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system.
Krauze AV; Peters C; Cheng J; Ning H; Mackey M; Rowe L; Cooley-Zgela T; Smart DD; Camphausen K
Radiat Oncol; 2017 Nov; 12(1):191. PubMed ID: 29187219
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge.
Navarria P; Ascolese AM; Tomatis S; Reggiori G; Clerici E; Villa E; Maggi G; Bello L; Pessina F; Cozzi L; Scorsetti M
Cancer Res Treat; 2016 Jan; 48(1):37-44. PubMed ID: 25761491
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review.
Kulinich DP; Sheppard JP; Nguyen T; Kondajji AM; Unterberger A; Duong C; Enomoto A; Patel K; Yang I
Acta Neurochir (Wien); 2021 Jul; 163(7):1921-1934. PubMed ID: 33796887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
